Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT05864976
- Status
- Recruiting
Conditions
- Glioblastoma Multiforme
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Support Vector Machine — DEVICEMachine learning algorithm
Study Details
This study is investigating the use of a computer algorithm to analyze scans of the brain before surgery to predict how a person's tumor will respond to treatment.
Key Dates
- Start date
- Dec 6, 2023
- Status verified
- Jun 2025
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2030
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Standard of care rsfMRI using the Support Vector Machine algorithm* Once enrolled, clinical pre-surgical MRI will be done on Siemens 3T Prisma or Skyra scanners using a standard pre-surgical tumor protocol. Resting-state functional MRI (rsfMRI) will be acquired. The Support Vector Machine (SVM) algorithm will be used on this pre-surgical MRI. * Patients will undergo post-operative MRI at approximately 8-12 weeks following surgical resection to evaluate extent of resection. Patients will then undergo subsequent MRI imaging every 2-3 months as part of routine clinical care to monitor for recurrence. The following MR sequences will be acquired: pre-and post-contrast T1-weighted, T2-weighted FLAIR, diffusion weighted imaging. MRI scans will be reviewed by a board-certified neuroradiologist to determine date of radiographic progression/recurrence. Imaging features at recurrence including location, multifocality, and presence of diffuse or distant recurrence will also be recorded.
Primary Outcome Measure
Number of participants who are deemed as short-term survivor or a long-term survivor [ Time Frame: Through completion of follow-up (estimated to be 2 years) ]
Central Contacts
- Dimitrios Mathios, M.D.314-747-6146
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63110 | Dimitrios Mathios, M.D. (PRINCIPAL_INVESTIGATOR) Joshua Shimony, M.D. (SUB_INVESTIGATOR) Milan Chheda, M.D. (SUB_INVESTIGATOR) Abraham Synder, M.D., Ph.D. (SUB_INVESTIGATOR) Patrick Luckett, Ph.D. (SUB_INVESTIGATOR) Feng Gao, Ph.D. (SUB_INVESTIGATOR) Eric Leuthardt, M.D. (SUB_INVESTIGATOR) |
Find similar trials in St Louis, MO
By research site
Related Studies
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsPHASE1 · Recruiting · M.D. Anderson Cancer Center · Birmingham, Alabama
- Sonobiopsy for Noninvasive and Sensitive Detection of GlioblastomaRecruiting · Washington University School of Medicine · St Louis, Missouri
- A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMPHASE1 · Recruiting · Boston Scientific Corporation · Birmingham, Alabama
- Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma MultiformeRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland